Cargando…

Pharmageddon /

"This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in health care that are leading to a growing number of deaths and disabilities. Healy, who was the first to draw attention to the now well-public...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Healy, David, 1954-
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berkeley : University of California Press, ©2012.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ma 4500
001 JSTOR_ocn774290524
003 OCoLC
005 20231005004200.0
006 m o d
007 cr cn|||||||||
008 110617s2012 cau ob 001 0 eng d
040 |a E7B  |b eng  |e pn  |c E7B  |d N$T  |d YDXCP  |d TEFOD  |d CDX  |d OCLCQ  |d JSTOR  |d OCLCF  |d EBLCP  |d MEAUC  |d DEBBG  |d IUL  |d AZU  |d WAU  |d DEBSZ  |d IDEBK  |d CHVBK  |d OCLCA  |d TEFOD  |d OCLCQ  |d AZK  |d JBG  |d AGLDB  |d MOR  |d PIFAG  |d ZCU  |d OCLCQ  |d MERUC  |d OCLCQ  |d OCLCO  |d RRP  |d OCLCA  |d U3W  |d OCLCA  |d KIJ  |d STF  |d WRM  |d VNS  |d VTS  |d ICG  |d VT2  |d REC  |d AU@  |d OCLCQ  |d WYU  |d LVT  |d S9I  |d TKN  |d OCLCO  |d DKC  |d OCLCO  |d OCLCQ  |d OCLCO  |d DEGRU  |d OCLCQ  |d OCLCA  |d AJS  |d OCLCO  |d INARC  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO 
019 |a 768731996  |a 778618592  |a 792880655  |a 816878007  |a 824105648  |a 961595870  |a 962597911  |a 1058173722 
020 |a 9780520951815  |q (electronic bk.) 
020 |a 0520951816  |q (electronic bk.) 
020 |a 1283369745 
020 |a 9781283369749 
020 |z 9780520270985  |q (cloth alk. paper) 
020 |z 0520270983  |q (cloth ;  |q alk. paper) 
024 8 |a 9786613369741 
029 1 |a AU@  |b 000053296508 
029 1 |a CHBIS  |b 010204840 
029 1 |a CHVBK  |b 319574075 
029 1 |a DEBBG  |b BV039868213 
029 1 |a DEBBG  |b BV043056233 
029 1 |a DEBBG  |b BV044188015 
029 1 |a DEBSZ  |b 397174152 
029 1 |a DEBSZ  |b 446429716 
029 1 |a NZ1  |b 15198878 
035 |a (OCoLC)774290524  |z (OCoLC)768731996  |z (OCoLC)778618592  |z (OCoLC)792880655  |z (OCoLC)816878007  |z (OCoLC)824105648  |z (OCoLC)961595870  |z (OCoLC)962597911  |z (OCoLC)1058173722 
037 |a 22573/cttt2kx3  |b JSTOR 
037 |a 0F8132C2-A207-4BAE-8DBD-16238335A4E1  |b OverDrive, Inc.  |n http://www.overdrive.com 
043 |a n-us--- 
050 4 |a RM300  |b .H43 2012eb 
060 4 |a QV 736 
072 7 |a BUS  |x 070080  |2 bisacsh 
072 7 |a MED035000  |2 bisacsh 
072 7 |a KNDP  |2 bicssc 
082 0 4 |a 338.4/76153  |2 23 
049 |a UAMI 
100 1 |a Healy, David,  |d 1954- 
245 1 0 |a Pharmageddon /  |c David Healy. 
260 |a Berkeley :  |b University of California Press,  |c ©2012. 
300 |a 1 online resource (xii, 302 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
504 |a Includes bibliographical references and index. 
505 0 |a They used to call it medicine -- Medicine and the marketeers -- Follow the evidence -- Doctoring the data -- Trussed in guidelines -- The mismeasurement of medicine -- The eclipse of care -- Pharmageddon. 
520 |a "This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in health care that are leading to a growing number of deaths and disabilities. Healy, who was the first to draw attention to the now well-publicized suicide-inducing side effects of many anti-depressants, attributes our current state of affairs to three key factors: product rather than process patents on drugs, the classification of certain drugs as prescription-only, and industry-controlled drug trials. These developments have tied the survival of pharmaceutical companies to the development of blockbuster drugs, so that they must overhype benefits and deny real hazards. Healy further explains why these trends have basically ended the possibility of universal health care in the United States and elsewhere around the world. He concludes with suggestions for reform of our currently corrupted evidence-based medical system"--Provided by publisher. 
590 |a JSTOR  |b Books at JSTOR Evidence Based Acquisitions 
590 |a JSTOR  |b Books at JSTOR Demand Driven Acquisitions (DDA) 
590 |a JSTOR  |b Books at JSTOR All Purchased 
650 0 |a Pharmacology. 
650 0 |a Medicine. 
650 0 |a Pharmaceutical industry. 
650 0 |a Drug utilization. 
650 1 2 |a Drug Industry 
650 2 2 |a Drug Utilization 
650 2 |a Pharmacology 
650 2 |a Medicine 
650 6 |a Pharmacologie. 
650 6 |a Médecine. 
650 6 |a Industrie pharmaceutique. 
650 6 |a Médicaments  |x Usage. 
650 7 |a pharmacology.  |2 aat 
650 7 |a medicines (material)  |2 aat 
650 7 |a medicine (discipline)  |2 aat 
650 7 |a BUSINESS & ECONOMICS  |x Industries  |x Service.  |2 bisacsh 
650 7 |a MEDICAL  |x Health Care Delivery.  |2 bisacsh 
650 7 |a Pharmaceutical industry  |2 fast 
650 7 |a Drug utilization  |2 fast 
650 7 |a Medicine  |2 fast 
650 7 |a Pharmacology  |2 fast 
776 0 8 |i Print version:  |a Healy, David, MRC Psych.  |t Pharmageddon.  |d Berkeley : University of California Press, ©2012  |w (DLC) 2011026063 
856 4 0 |u https://jstor.uam.elogim.com/stable/10.1525/j.ctt1ppcq6  |z Texto completo 
938 |a Internet Archive  |b INAR  |n pharmageddon0000heal 
938 |a Coutts Information Services  |b COUT  |n 20354388 
938 |a De Gruyter  |b DEGR  |n 9780520951815 
938 |a EBL - Ebook Library  |b EBLB  |n EBL816489 
938 |a ebrary  |b EBRY  |n ebr10518901 
938 |a EBSCOhost  |b EBSC  |n 413318 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n 336974 
938 |a YBP Library Services  |b YANK  |n 7283934 
994 |a 92  |b IZTAP